Natera Hid Prenatal Test Authorization Scheme, Investor Says
A shareholder of genetic testing manufacturer Natera Inc. has claimed that the company hid from investors a scheme in which it worked with a third party to submit prior authorization requests...To view the full article, register now.
Already a subscriber? Click here to view full article